|Save ComparisonClear all|
KinDex was established to focus on the discovery and development of molecules that improve women’s health and impact chronic disease.
Vtesse's lead compound, VTS-270, has shown promise in pre-clinical and clinical studies as a potential treatment for Niemann-Pick Disease.
ADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products.
Therapeutic Solutions International
Therapeutic Solutions International focuses on immune modulation for the treatment of various diseases.
Alzheon is committed to developing breakthrough medicines for patients suffering from Alzheimer's disease and other neurological disorders.
Seattle, US HQ
Gaithersburg, US HQ
Epalinges, CH HQ
Greater London, GB
San Mateo, US
New Providence, US
Oceanside, US HQ
Framingham, US HQ
Latest funding round
Latest funding round$ 327.3k (over 1 year ago)
Latest funding round$ 17m (almost 2 years ago)
Latest funding round$ 200m (7 months ago)
Latest funding roundN/A
Latest funding round$ 15.8m (12 months ago)
Total funding raised
Total funding raised$ 5.8m
Total funding raised$ 67m
Total funding raised$ 425m
Total funding raisedN/A
Total funding raised$ 37.1m